Relationship between renal and cardiovascular changes in a murine model of glucose intolerance

Regulatory Peptides

Volumn 139, Issue 1-3, 2007, Pages 1-4

  Cunha, Tatiana S ^a,b   Farah, Vera ^a   Paulini, Janaina ^a   Pazzine, Mariana ^a   Elased, Khalid M ^a   Marcondes, Fernanda K ^b   Cláudia Irigoyen, Maria ^c   De Angelis, Kátia ^c,d   Mirkin, L David ^a   Morris, Mariana ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d SÃO JUDAS TADEU UNIVERSITY   (Brazil)

Author keywords

Blood pressure variability; Cardiovascular function; Diabetes; Metabolism; Renin angiotensin system

Indexed keywords

ANGIOTENSIN II; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; FRUCTOSE; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE VARIABILITY; BODY WEIGHT; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HISTOLOGY; INSULIN BLOOD LEVEL; KIDNEY FUNCTION; KIDNEY MASS; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; URINARY EXCRETION; URINE VOLUME;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; GLUCOSE INTOLERANCE; KIDNEY; MALE; MICE; MICE, INBRED C57BL;

BOVINE PARVOVIRUS; MURINAE; MUS;

EID: 33846785566     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.11.023     Document Type: Article

References (24)

1. Tanaka H., Shiohira Y., Uezu Y., Higa A., and Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 69 (2006) 369-374
2. Astrup A., and Finer N. Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'?. Obes Rev 1 (2000) 57-59
3. Group DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
4. Borch-Johnsen K., and Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. BMJ 294 (1987) 1651-1654
5. Ruilope L.M., Campo C., Rodriguez-Artalejo F., Lahera V., Garcia-Robles R., and Rodicio J.L. Blood pressure and renal function: therapeutic implications. J Hypertens 14 (1996) 1259-1263
6. Aurell M., and Bjorck S. Determinants of progressive renal disease in diabetes mellitus. Kidney Int Suppl 36 (1992) S38-S42
7. Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Morales P.A., and Stern M.P. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41 (1992) 715-722
8. Farah V., Elased K.M., Chen Y., Key M.P., Cunha T.S., Irigoyen M.C., and Morris M. Nocturnal hypertension in mice consuming a high fructose diet. Auton Neurosci 130 (2006) 41-50
9. Iseki K., Ikemiya Y., Iseki C., and Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 63 (2003) 1468-1474
10. Noonan W.T., and Banks R.O. Renal function and glucose transport in male and female mice with diet-induced type II diabetes mellitus. Proc Soc Exp Biol Med 225 (2000) 221-230
11. Teixeira S.R., Tappenden K.A., and Erdman Jr. J.W. Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m +Lepr db/+Lepr db (db/db) mice. J Nutr 133 (2003) 673-678
12. Menne J., Park J.K., Boehne M., Elger M., Lindschau C., Kirsch T., Meier M., Gueler F., Fiebeler A., Bahlmann F.H., Leitges M., and Haller H. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. Diabetes 53 (2004) 2101-2109
13. Bernobich E., Cosenzi A., Campa C., Zennaro C., Sasso F., Paoletti S., and Bellini G. Antihypertensive treatment and renal damage: amlodipine exerts protective effect through the polyol pathway. J Cardiovasc Pharmacol 44 (2004) 401-406
14. McPherson J.D., Shilton B.H., and Walton D.J. Role of fructose in glycation and cross-linking of proteins. Biochemistry 27 6 (1988) 1901-1907
15. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Investig 34 (2004) 785-796
16. The EUCLID Study Group. Randomized placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 349 (1997) 1787-1792
17. Wichi RB, Farah V, Chen Y, Irigoyen MC, Morris M. Deficiency in angiotensin AT1a receptors prevents diabetes-induced hypertension. Am J Physiol Regul Integr Comp Physiol in press, [Eletronic publication ahead of print, November 22].
18. Tikellis C., Johnston C.I., Forbes J.M., Burns W.C., Burrell L.M., Risvanis J., and Cooper M.E. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 41 (2003) 392-397
19. Stauss H.M., Mrowka R., Nafz B., Patzak A., Unger T., and Persson P.B. Does low frequency power of arterial blood pressure reflect sympathetic tone?. J Auton Nerv Syst 54 (1995) 145-154
20. Adamczak M., Zeier M., Dikow R., and Ritz E. Kidney and hypertension. Kidney Int Suppl (2002) 62-67
21. Fabiani M.E., Sourial M., Thomas W.G., Johnston C.I., Johnston C.I., and Frauman A.G. Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia. J Endocrinol 171 (2001) 97-108
22. Reddi A.S., Nimmagadda V.R., Lefkowitz A., Kuo H.R., and Bollineni J.S. Effect of antihypertensive therapy on renal injury in type 2 diabetic rats with hypertension. Hypertension 36 (2000) 233-238
23. Jafar T.H., Schmid C.H., Landa M., Giatras I., Toto R., Remuzzi G., Maschio G., Brenner B.M., Kamper A., Zucchelli P., Becker G., Himmelmann A., Bannister K., Landais P., Shahinfar S., de Jong P.E., de Zeeuw D., Lau J., and Levey A.S. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135 (2001) 73-87
24. Su D.F., and Miao C.Y. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol 28 (2001) 709-715